List of Oryzon Genomics patents

List of Oryzon Genomics patents

List of AltaRock Energy patents

List of Korea Gas Corporation patents

List of New York University Press patents

Companies in the Eyewear industry

List of companies in Govtech Fund's investment portfolio

Patents where

Current Assignee

Name

is

Oryzon Genomics

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9006449 Cyclopropylamine derivatives useful as LSD1 inhibitors	Patent 9006449 was granted and assigned to Oryzon Genomics on April, 2015 by the United States Patent and Trademark Office.		Oryzon Genomics		United States Patent and Trademark Office	9006449	April 14, 2015
	‌ US Patent 8946296 Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use	Patent 8946296 was granted and assigned to Oryzon Genomics on February, 2015 by the United States Patent and Trademark Office.		Oryzon Genomics		United States Patent and Trademark Office	8946296	February 3, 2015
	‌ US Patent 9186337 Lysine demethylase inhibitors for diseases and disorders associated with	Patent 9186337 was granted and assigned to Oryzon Genomics on November, 2015 by the United States Patent and Trademark Office.		Oryzon Genomics		United States Patent and Trademark Office	9186337	November 17, 2015
	‌ US Patent 9149447 Lysine specific demethylase-1 inhibitors and their use	Patent 9149447 was granted and assigned to Oryzon Genomics on October, 2015 by the United States Patent and Trademark Office.		Oryzon Genomics		United States Patent and Trademark Office	9149447	October 6, 2015
	‌ US Patent 8722743 Lysine specific demethylase-1 inhibitors and their use	Patent 8722743 was granted and assigned to Oryzon Genomics on May, 2014 by the United States Patent and Trademark Office.		Oryzon Genomics		United States Patent and Trademark Office	8722743	May 13, 2014
	‌ US Patent 8993808 Phenylcyclopropylamine derivatives and their medical use	Patent 8993808 was granted and assigned to Oryzon Genomics on March, 2015 by the United States Patent and Trademark Office.		Oryzon Genomics		United States Patent and Trademark Office	8993808	March 31, 2015
	‌ US Patent 7745127 Molecular diagnostic method for dementia with lewy bodies	Patent 7745127 was granted and assigned to Oryzon Genomics on June, 2010 by the United States Patent and Trademark Office.		Oryzon Genomics		United States Patent and Trademark Office	7745127	June 29, 2010
	‌ US Patent 8859555 Lysine Specific Demethylase-1 inhibitors and their use	Patent 8859555 was granted and assigned to Oryzon Genomics on October, 2014 by the United States Patent and Trademark Office.		Oryzon Genomics		United States Patent and Trademark Office	8859555	October 14, 2014
	‌ US Patent 8524717 Oxidase inhibitors and their use	Patent 8524717 was granted and assigned to Oryzon Genomics on September, 2013 by the United States Patent and Trademark Office.		Oryzon Genomics		United States Patent and Trademark Office	8524717	September 3, 2013

9 results

0 selected

9 results

0 selected